NICE Recommends Forxiga for Marketing Authorization February 4, 2022 Auto Bot News 0 The UK’s NICE issued a Final Appraisal Document recommending marketing authorization for AstraZeneca’s chronic kidney disease treatment, Forxiga (dapagliflozin).